LEUKEMIA

CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages

Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome

Chronic myeloid leukemia stem cells

S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes

Inhibitory effects of midostaurin and avapritinib on myeloid progenitors derived from patients with KIT D816V positive advanced systemic mastocytosis

LAMP2 expression dictates azacytidine response and prognosis in MDS/AML

Prognostic impact of RAS-pathway mutations in patients with myelofibrosis

The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation

Recurrent PDGFRB mutations in unicentric Castleman disease

The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution

The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells.

A revised international prognostic score system for Waldenström’s macroglobulinemia

Familial myeloid malignancies with germline TET2 mutation

The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma

CXCR5+CD8+ T cells are a distinct functional subset with antitumor activity

Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS): comparison with multiple myeloma

Telomere length predicts for outcome to FCR chemotherapy in CLL

Rethinking clinical trial endpoints in myelodysplastic syndromes

Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia

Heritable variation at the chromosome 21 gene ERG is associated with acute lymphoblastic leukemia risk in children with and without Down syndrome

Humanized CD19-specific chimeric antigen-receptor T-cells in 2 adults with newly diagnosed B-cell acute lymphoblastic leukemia

Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis

Integrative phosphoproteome and interactome analysis of the role of Ubash3b in BCR-ABL signaling

PIM1 inhibition effectively enhances plerixafor-induced HSC mobilization by counteracting CXCR4 upregulation and blocking CXCL12 secretion

Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies

An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring

Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm

Blocking ATM-dependent NF-κB pathway overcomes niche protection and improves chemotherapy response in acute lymphoblastic leukemia

Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children’s Oncology Group Studies P9904 and P9905

Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance

Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes

Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis

Molecular characterization of a second myeloid neoplasm developing after treatment for acute myeloid leukemia

Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes

Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice

The BET Inhibitor GS-5829 Targets Chronic Lymphocytic Leukemia Cells and Their Supportive Microenvironment

The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation

Correction: LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML

Comparison of minimal residual disease levels in bone marrow and peripheral blood in adult acute lymphoblastic leukemia

Dichotomous Toll-like receptor responses in chronic lymphocytic leukemia patients under ibrutinib treatment

Recommendations for cytogenomic analysis of hematologic malignancies: comments from the Francophone Group of Hematological Cytogenetics (GFCH)

On the road to molecular prognostication in SMM

Unexpected variation in leukemia stem cell frequency and genetic heterogeneity in two murine leukemia models initiated by AML1/ETO9a and CALM/AF10

Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role

Carfilzomib-induced reticulocytosis in patients with multiple myeloma is caused by impaired terminal erythroid maturation

Clonal hematopoiesis by SLIT1-mutated hematopoietic stem cells due to a breakdown of the autocrine loop involving Slit1 in acquired aplastic anemia

Hematopoietic stem cell transplantation for adults with T-cell lymphoblastic lymphoma: can we successfully step into the era of precision medicine?